PBLA
Price
$0.59
Change
+$0.06 (+11.32%)
Updated
Dec 1, 6:59 PM EST
VSTM
Price
$7.01
Change
+$0.17 (+2.49%)
Updated
Dec 1, 6:59 PM EST
Ad is loading...

Compare predictions PBLA vs VSTM

Header iconPBLA vs VSTM Comparison
Open Charts PBLA vs VSTMBanner chart's image
Panbela Therapeutics
Price$0.59
Change+$0.06 (+11.32%)
Volume$169.4K
CapitalizationN/A
Verastem
Price$7.01
Change+$0.17 (+2.49%)
Volume$28.59K
CapitalizationN/A
View a ticker or compare two or three
PBLA vs VSTM Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
PBLA vs. VSTM commentary
Dec 02, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBLA is a StrongBuy and VSTM is a StrongBuy.

COMPARISON
Comparison
Dec 02, 2023
Stock price -- (PBLA: $0.60 vs. VSTM: $6.91)
Brand notoriety: PBLA and VSTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PBLA: 21% vs. VSTM: 96%
Market capitalization -- PBLA: $2.58M vs. VSTM: $165.5M
PBLA [@Biotechnology] is valued at $2.58M. VSTM’s [@Biotechnology] market capitalization is $165.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBLA’s FA Score shows that 1 FA rating(s) are green whileVSTM’s FA Score has 0 green FA rating(s).

  • PBLA’s FA Score: 1 green, 4 red.
  • VSTM’s FA Score: 0 green, 5 red.
According to our system of comparison, VSTM is a better buy in the long-term than PBLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBLA’s TA Score shows that 6 TA indicator(s) are bullish while VSTM’s TA Score has 4 bullish TA indicator(s).

  • PBLA’s TA Score: 6 bullish, 2 bearish.
  • VSTM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PBLA is a better buy in the short-term than VSTM.

Price Growth

PBLA (@Biotechnology) experienced а +15.03% price change this week, while VSTM (@Biotechnology) price change was +2.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.15%. For the same industry, the average monthly price growth was +30.64%, and the average quarterly price growth was +27.15%.

Reported Earning Dates

PBLA is expected to report earnings on May 16, 2023.

VSTM is expected to report earnings on Aug 08, 2023.

Industries' Descriptions

@Biotechnology (+3.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for PBLA with price predictions.
OPEN
A.I.dvisor published
a Summary for VSTM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VSTM($166M) has a higher market cap than PBLA($2.58M). VSTM YTD gains are higher at: 43.064 vs. PBLA (-99.319). PBLA has higher annual earnings (EBITDA): -23.28M vs. VSTM (-73.06M). VSTM has more cash in the bank: 166M vs. PBLA (907K). PBLA has less debt than VSTM: PBLA (5.19M) vs VSTM (42M). PBLA (0) and VSTM (0) have equivalent revenues.
PBLAVSTMPBLA / VSTM
Capitalization2.58M166M2%
EBITDA-23.28M-73.06M32%
Gain YTD-99.31943.064-231%
P/E Ratio0.00N/A-
Revenue00-
Total Cash907K166M1%
Total Debt5.19M42M12%
FUNDAMENTALS RATINGS
PBLA vs VSTM: Fundamental Ratings
PBLA
VSTM
OUTLOOK RATING
1..100
3116
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
42
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9560
P/E GROWTH RATING
1..100
95100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PBLA's Valuation (11) in the null industry is in the same range as VSTM (42) in the Biotechnology industry. This means that PBLA’s stock grew similarly to VSTM’s over the last 12 months.

PBLA's Profit vs Risk Rating (100) in the null industry is in the same range as VSTM (100) in the Biotechnology industry. This means that PBLA’s stock grew similarly to VSTM’s over the last 12 months.

VSTM's SMR Rating (98) in the Biotechnology industry is in the same range as PBLA (100) in the null industry. This means that VSTM’s stock grew similarly to PBLA’s over the last 12 months.

VSTM's Price Growth Rating (60) in the Biotechnology industry is somewhat better than the same rating for PBLA (95) in the null industry. This means that VSTM’s stock grew somewhat faster than PBLA’s over the last 12 months.

PBLA's P/E Growth Rating (95) in the null industry is in the same range as VSTM (100) in the Biotechnology industry. This means that PBLA’s stock grew similarly to VSTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PBLAVSTM
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALLR0.590.04
+6.68%
Allarity Therapeutics
CCNE20.750.41
+2.02%
CNB Financial Corp
HNI39.690.62
+1.59%
HNI Corp
BWA33.950.26
+0.77%
BorgWarner
FORA2.70-0.01
-0.37%
Forian

PBLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBLA has been closely correlated with VSTM. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if PBLA jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBLA
1D Price
Change %
PBLA100%
+13.00%
VSTM - PBLA
77%
Closely correlated
+0.29%
APLMW - PBLA
35%
Loosely correlated
+2.56%
VANI - PBLA
26%
Poorly correlated
+0.67%
SPRO - PBLA
24%
Poorly correlated
+2.63%
CLNN - PBLA
24%
Poorly correlated
-1.83%
More